HPV vaccination is not only for girls or cervical cancer prevention. Men can get human papillomavirus through intimate skin-to-skin contact, including vaginal, anal, and oral sex, and some HPV types can lead to genital warts, anal cancer, penile cancer, and cancers of the throat. The vaccine works best before exposure to HPV, which is why it is routinely recommended in early adolescence. Still, many adult men missed the vaccine when they were younger and wonder whether it is too late.
In the United States, HPV vaccination is recommended for everyone through age 26 if they were not fully vaccinated earlier. From ages 27 through 45, it is not routine for every man, but some may benefit after discussing their sexual history and future risk with a clinician. After age 45, HPV vaccines are not licensed in the U.S.
Table of Contents
- Age Cutoffs for Men: Who Should Get the HPV Vaccine?
- Why the Vaccine Matters for Men’s Health
- How Many Doses Men Need
- Men 27 to 45: Who Might Benefit Most?
- What the Vaccine Can and Cannot Do
- Sex, Relationships, and Risk Questions
- Side Effects, Safety, and When to Wait
- How to Get Vaccinated and What to Ask
Age Cutoffs for Men: Who Should Get the HPV Vaccine?
In the U.S., the clearest answer is this: boys and men should be vaccinated through age 26 if they have not already completed the HPV vaccine series. The routine age is 11 or 12, but the vaccine can be started as early as age 9.
For adult men, the most common cutoff question is whether the vaccine still makes sense after the teen years. It often does through age 26. A man who is 19, 22, or 25 and never received the vaccine does not need a special reason to start. He is still in the catch-up age range.
From ages 27 through 45, the recommendation changes. Vaccination is not automatically recommended for every adult in this age group. Instead, it is based on shared decision-making with a healthcare professional. That means the clinician and patient look at the man’s past vaccination status, likely prior HPV exposure, relationship situation, and chance of future new partners.
After age 45, HPV vaccines are not licensed in the U.S. That does not mean HPV suddenly stops mattering at 46. It means available vaccine approval and national recommendations do not extend beyond that age.
| Age | General guidance | What it usually means |
|---|---|---|
| 9 to 10 | May start | Some families and clinicians choose early vaccination before middle school. |
| 11 to 12 | Routine vaccination | This is the preferred age because protection is strongest before sexual exposure. |
| 13 to 26 | Catch-up vaccination | Men who missed the vaccine earlier should complete the series. |
| 27 to 45 | Discuss with a clinician | Some men may benefit, especially if they could have new sexual partners in the future. |
| Over 45 | Not licensed in the U.S. | Routine vaccination is not recommended under U.S. guidance. |
A man does not need to know whether he has had HPV before getting vaccinated. There is no routine pre-vaccine HPV test for men that can reliably answer whether the vaccine would help. The decision is usually based on age, vaccine history, and future exposure risk.
Why the Vaccine Matters for Men’s Health
HPV can affect men directly. Some types cause genital warts. Other types can persist for years and raise the risk of anal, penile, and oropharyngeal cancers. Oropharyngeal cancers affect the tonsils, base of the tongue, and back of the throat.
Most HPV infections do not cause symptoms and clear on their own. That is one reason the virus spreads easily. A man can have HPV without seeing bumps, rash, discharge, pain, or any other obvious sign. For a deeper look at symptoms and testing limits, see HPV in men.
The vaccine protects against the HPV types most strongly linked with cancer and the types that cause most genital warts. In the U.S., the currently used vaccine is the 9-valent HPV vaccine, often called Gardasil 9. “9-valent” means it targets nine HPV types.
The strongest cancer-prevention value comes from vaccinating before exposure. Once someone has already acquired a specific HPV type, the vaccine does not clear that infection. But prior sexual activity does not mean a man has been exposed to every vaccine-covered type. That is why catch-up vaccination through age 26 can still be worthwhile.
For men, HPV vaccination can help reduce the risk of:
- Genital warts
- Anal cancer
- Penile cancer
- HPV-related throat cancers
- Passing vaccine-covered HPV types to future partners
Genital warts are not cancer, but they can be stressful, uncomfortable, recurrent, and easy to confuse with other bumps. Men who already have visible bumps should be evaluated rather than guessing, because genital warts can look different from person to person.
HPV vaccination also has a partner-protection effect. Lowering HPV infection in men can lower transmission risk in sexual networks. That matters for female partners because HPV is the main cause of cervical cancer, and it matters for male partners because HPV can also cause anal and throat cancers.
How Many Doses Men Need
The number of HPV vaccine doses depends mainly on the age when the first dose is given and whether the person has a weakened immune system.
Most boys who start before their 15th birthday need two doses. The second dose is usually given 6 to 12 months after the first. If the two doses are given too close together, a third dose may be needed.
Men who start the series at age 15 or older usually need three doses. The common schedule is:
- First dose: now
- Second dose: 1 to 2 months after the first dose
- Third dose: about 6 months after the first dose
People with certain immunocompromising conditions generally need three doses even if they start younger. This includes some people with HIV, some transplant recipients, and others whose immune systems may not respond as strongly.
If a man started the HPV vaccine years ago but never finished, he usually does not need to restart from the beginning. In most cases, he can continue where he left off. For example, if he got one dose at 18 and is now 23, he should ask about completing the remaining doses.
Missing the exact timing is common. A late dose is usually still useful. A dose given too early may not count, so it is worth checking the vaccine record rather than guessing.
Men who do not remember whether they received the vaccine should try to find records from:
- A pediatrician or family doctor
- A college health center
- A state immunization registry
- A pharmacy vaccine record
- Military, workplace, or travel clinic records
If records cannot be found, a clinician can advise whether vaccination should be given or completed. Extra doses are not usually the goal, but uncertain records are common enough that healthcare offices deal with this situation often.
Men 27 to 45: Who Might Benefit Most?
A man between 27 and 45 is not automatically “too old,” but the expected benefit is usually smaller than it is for teens and young adults. Many adults have already been exposed to HPV, especially if they have had multiple sexual partners. The vaccine prevents new infections; it does not erase old exposure.
The men most likely to consider vaccination in this age range are those who may have new sexual partners in the future. A 34-year-old who is recently divorced and dating again may have a different risk profile from a 34-year-old in a long-term mutually monogamous relationship.
Vaccination may be worth discussing for men ages 27 to 45 who:
- Never received the HPV vaccine or did not complete the series
- Expect new sexual partners in the future
- Are dating after divorce or the end of a long relationship
- Have sex with men
- Have a partner with HPV-related disease
- Have had few previous partners but may have new partners
- Have HIV or another immune condition and are not fully vaccinated
- Want to reduce the chance of future vaccine-type HPV infection, while understanding the limits
A man in a long-term mutually monogamous relationship is less likely to get a new HPV infection if both partners remain monogamous. In that situation, the vaccine may offer little added benefit. But relationship status can change, and some men prefer to think about future risk rather than only current risk.
Men who have sex with men may be more likely to discuss HPV vaccination because anal HPV infection and anal cancer risk are important concerns in this group, especially for those with HIV. The same age limits still matter: routine catch-up is through age 26, and ages 27 through 45 involve individual discussion.
This decision should not be based on shame, blame, or assumptions about someone’s past. HPV is extremely common. The useful question is not “Have I ever been exposed?” but “Could I still benefit from protection against HPV types I may not have encountered?”
What the Vaccine Can and Cannot Do
HPV vaccination prevents future infection with vaccine-covered HPV types. It does not treat current HPV infection, remove genital warts, cure abnormal cells, or make a positive HPV-related finding go away.
That difference matters. A man who gets vaccinated after being treated for genital warts may still need treatment or follow-up for the warts he already has. The vaccine may help protect against other HPV types, but it is not a wart treatment.
The vaccine also does not replace safer sex habits. Condoms can lower HPV risk, but they do not cover all skin that can carry the virus. HPV can spread through contact with areas not covered by a condom. Still, condoms remain important because they reduce the risk of many infections, including chlamydia, gonorrhea, HIV, and syphilis. Men who want to lower STI risk should also pay attention to condom fit and common condom mistakes.
HPV vaccination does not replace evaluation for symptoms. Men should get checked if they notice:
- New genital, anal, or mouth bumps
- A sore that does not heal
- Bleeding from the anus or penis
- Penile discharge
- Pain with sex or urination
- A lump in the groin
- Persistent throat symptoms, trouble swallowing, or a neck lump
Most of these symptoms are not cancer, but they should not be ignored. Bumps may be warts, ingrown hairs, pearly penile papules, molluscum, herpes, cysts, or irritation. The right treatment depends on the cause.
There is also no routine HPV screening test for most men. Cervical HPV tests are used in cervical cancer screening, but that does not translate into a simple “HPV test for men” before vaccination. Some high-risk groups may be offered anal cancer screening in certain clinics, but that is separate from deciding whether to get vaccinated.
Men who recently had a possible STI exposure should not rely on HPV vaccination as their only step. Timing matters for different infections, and some tests are more accurate after a waiting period. For STI timing questions, when to get STI tested is often just as important as which test to order.
Sex, Relationships, and Risk Questions
HPV risk is tied more to exposure over time than to a single label such as “low risk” or “high risk.” A man can get HPV from one partner. He can also have HPV without knowing it. The virus can be transmitted even when there are no visible warts.
New partners are the biggest future-risk factor. That includes new vaginal, anal, or oral sex partners. Oral HPV is one reason vaccination matters for men, because HPV-related throat cancers are an important male health concern.
A man may reasonably ask about vaccination in several real-world situations.
A 21-year-old college student who never got the vaccine should start it. He is within the catch-up age range, and no special risk discussion is needed.
A 29-year-old who had only one long-term partner but is dating again may benefit. He may not have encountered all vaccine-covered HPV types, and future exposure is possible.
A 38-year-old in a mutually monogamous marriage of 12 years may receive little added benefit if the relationship remains mutually monogamous. He can still ask, but vaccination may not be a priority.
A 42-year-old man who has sex with men and has new partners may have a stronger reason to discuss vaccination than a man of the same age with no expected future partners.
A 47-year-old who missed vaccination is outside the licensed U.S. age range. He should focus on symptom awareness, safer sex, smoking avoidance, and appropriate medical evaluation if problems appear.
Smoking is worth mentioning because it can weaken local immune defenses and is linked with several cancers. HPV vaccination is one prevention tool, not the only one. For broader prevention planning, men can review vaccines men need by age, especially if they are behind on other routine vaccines.
Sexual orientation does not change the basic vaccine age schedule, but it can change the risk conversation. Men who have sex with men, bisexual men, transgender people, and men with HIV may have specific screening or prevention needs beyond the HPV vaccine. A clinician familiar with sexual health can help sort out vaccines, STI testing, HIV prevention, and anal health concerns without judgment.
Side Effects, Safety, and When to Wait
Most HPV vaccine side effects are mild and short-lived. The most common reaction is soreness where the shot was given. Redness, swelling, headache, low-grade fever, tiredness, nausea, or muscle aches can also happen.
Fainting can happen after injections, especially in adolescents and young adults. This is not unique to the HPV vaccine. Many clinics ask people to sit or lie down during the shot and remain seated for about 15 minutes afterward.
A severe allergic reaction is rare but needs emergency care. Warning signs include trouble breathing, swelling of the face or throat, hives, fast heartbeat, dizziness, or weakness soon after vaccination.
A man should tell the vaccine provider if he:
- Had a severe allergic reaction to a previous HPV vaccine dose
- Has a severe allergy to a vaccine component
- Is moderately or severely ill on the day of vaccination
- Has a history of fainting with shots
- Has an immune condition or takes immune-suppressing medication
A mild cold is usually not a reason to delay vaccination. A high fever or significant acute illness may be a reason to wait until recovery, mostly so symptoms are not confused and the body is not dealing with another illness at the same time.
HPV vaccines are not live vaccines. They do not contain HPV DNA that can infect someone. They cannot cause HPV infection, genital warts, or cancer.
Men sometimes worry that the vaccine might affect testosterone, fertility, erections, or sexual performance. HPV vaccination is not used to change hormones, and it is not known to lower testosterone or sperm production. Men who have fertility concerns should look for other common factors, such as heat exposure, smoking, anabolic steroid use, varicocele, medications, and medical conditions.
The vaccine can be given at the same visit as many other vaccines. A healthcare professional can confirm what is appropriate based on the person’s age, vaccine record, and health history.
How to Get Vaccinated and What to Ask
The easiest starting point is a primary care office, pharmacy, sexual health clinic, student health center, or local health department. Many men receive HPV vaccination at pharmacies, but availability can vary by age and state rules.
Before the visit, gather any vaccine records you can find. The most useful details are the dates of prior HPV doses and which vaccine was used, if listed. If you cannot find records, say that clearly. Do not assume you are fully vaccinated because you received “some shots” as a teen.
Good questions to ask include:
- “Am I already considered fully vaccinated?”
- “Do I need two doses or three?”
- “If I had one dose years ago, can I continue the series?”
- “At my age, what benefit should I realistically expect?”
- “Will insurance cover it?”
- “Do I have any allergy or immune-system issue that changes the plan?”
- “Should I also update other vaccines today?”
Insurance coverage is often straightforward through age 26, but it may vary for adults 27 through 45 because vaccination in that range is based on individual discussion. Checking coverage before the appointment can prevent surprise costs.
Men with symptoms should not delay evaluation while waiting for vaccine appointments. Vaccination can be handled separately from diagnosing a bump, sore, rash, discharge, or pain. A urologist, dermatologist, primary care doctor, or sexual health clinic may be appropriate depending on the symptom. Men with ongoing genital, urinary, prostate, fertility, or sexual health concerns may also consider when to see a men’s health specialist.
The most important step is not to assume it is too late without checking. A man under 27 who missed HPV vaccination should usually complete it. A man 27 to 45 should make a decision based on future exposure risk, not embarrassment about the past. A man over 45 should understand that vaccination is not licensed for his age group in the U.S., while still taking HPV-related symptoms seriously.
References
- HPV Vaccine Recommendations | HPV | CDC 2024 (Guideline)
- Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices 2019 (Guideline)
- Preventing HPV-Associated Cancers | Cancer | CDC 2024 (Official Page)
- HPV Vaccine VIS | Vaccines & Immunizations | CDC 2021 (Official Page)
- Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18-45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018-2023 2025 (Study)
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males 2011 (RCT)
Disclaimer
This article is for general education about HPV vaccination in men and should not replace care from a qualified healthcare professional. Vaccine recommendations can vary by country, health history, immune status, and prior vaccination record. Men with genital bumps, anal symptoms, throat symptoms, STI concerns, or questions about vaccination after age 26 should discuss their situation with a clinician.
